Inspire Announces Results From AZASITE(R) Phase 2 Blepharitis Trials And Plans To Continue Clinical Development In Anterior And Posterior Blepharitis

Links shared publicly online about this topic.

  • 1,308
    total visits

Inspire Announces Results From AZASITE(R) Phase 2 Blepharitis Trials And Plans To Continue Clinical Development In Anterior And Posterior Blepharitis

medicalnewstoday.com —

Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire wil

View full resource at medicalnewstoday.com

Tags: Eyelid Disorder, Pharma, Phase 2 Clinical Trial, Clinical Trial, Antibiotic, Zithromax, Zmax

  • Share

Most Recently Shared on March 17, 2010 at 3:11 pm By:

mnt_clinical MNT Clinical Trials

Inspire Announces Results From AZASITE(R) Phase 2 Blepharitis Trials And Plans To Continue Clinical Development In Ant... http://mnt.to/3z2x

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Eye Health MNT Eye Health

Advertisement